Dasashil 50 mg Tablet
  1. Home
  2. Pharma Products
  3. shilpa medicare
  4. Dasashil 50 mg Tablet

Dasashil 50 mg Tablet

Dasashil 50 mg Tablet contains dasatinib 50 mg, a targeted anticancer medicine belonging to the tyrosine kinase inhibitor class. It is used to treat certain blood cancers, including chronic myeloid leukemia and Philadelphia chromosome-positive acute lymphoblastic leukemia. The tablet is taken orally with or without food as prescribed by an oncologist.

BUY NOW

Category

Dasatinib blocks abnormal tyrosine kinase proteins such as BCR-ABL that promote the growth and survival of leukemia cells. Dasashil 50 mg is used in specific treatment settings for Philadelphia chromosome-positive leukemia. The product is manufactured by Shilpa Medicare Limited and is supplied in a bottle containing 60 tablets. Regular medical monitoring, including blood counts, may be required during treatment.

Technical Specification

Specification Details
Active Ingredient Dasatinib
Strength 50 mg
Dosage Form Tablet
Route of Administration Oral
Pack Size 60 tablets
Manufacturer Shilpa Medicare Limited

Product Also Known As

Dasashil 50 mg Tablet, Dasashil 50mg Tablet, Dasatinib 50 mg Tablet, Dasatinib 50mg Tablet, Dasatinib Anticancer Tablet, Dasatinib Leukemia Tablet, BCR-ABL Inhibitor Tablet